Literature DB >> 7852576

Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.

A Roth, B Roth, K N Arasteh, K Janitschke.   

Abstract

PCR was used to evaluate the occurrence of Toxoplasma gondii parasitemia by detection of the B1 gene in blood samples in two groups of immunosuppressed patients (148 subjects) suspected of having cerebral or extracerebral infection, respectively. Group I consisted of 52 patients with AIDS with suspected cerebral toxoplasmosis. The diagnosis was clinically proven in 15 cases. Parasitemia was detected by PCR in only two of these patients (13.3%), both showing evidence of disseminated infection. Group II consisted of 96 immunocompromised patients, either with AIDS or receiving iatrogenic immunosuppressive therapy. Of these patients, 65 (34 with AIDS and 31 others) showed abnormalities only in chest radiography and were first screened for the presence of Toxoplasma DNA in bronchoalveolar lavage fluid. Blood was then analyzed when the parasite was detected in the bronchoalveolar lavage fluid. The remaining 31 subjects (22 with AIDS and 9 others) were suspected of having extracerebral, pulmonary, or disseminated toxoplasmosis, and blood was studied directly in these cases. Among the nine patients with clinically diagnosed extracerebral infection in group II, the parasite was detected by PCR in the blood of five patients (55.5%), all having pulmonary toxoplasmosis. If all patients with clinical manifestations of extracerebral toxoplasmosis (from both groups) who had not received antitoxoplasma therapy when the samples were collected are considered, PCR detected parasitemia in seven of the nine cases (77.8%). The present study indicates that examination of blood by PCR may be valuable in cases of extracerebral toxoplasmosis because of the disseminated nature of the disease. Since most cases of cerebral toxoplasmosis result from the local reactivation of latent brain cysts, detection of parasitemia by PCR is useful only in cases associated with severe cerebral infection or dissemination of this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852576      PMCID: PMC264163          DOI: 10.1128/jcm.32.11.2813-2819.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Pulmonary toxoplasmosis.

Authors:  J R Catterall; J M Hofflin; J S Remington
Journal:  Am Rev Respir Dis       Date:  1986-04

2.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

Review 3.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Extracerebral toxoplasmosis in AIDS. Histological and immunohistological findings based on 80 autopsy cases.

Authors:  G Jautzke; M Sell; U Thalmann; K Janitschke; J Gottschalk; D Schürmann; B Ruf
Journal:  Pathol Res Pract       Date:  1993-05       Impact factor: 3.250

5.  Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction.

Authors:  N Cristina; H Pelloux; C Goulhot; J P Brion; P Leclercq; P Ambroise-Thomas
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

6.  Diagnosis of Toxoplasma parasitemia in patients with AIDS by gene detection after amplification with polymerase chain reaction.

Authors:  G A Filice; J A Hitt; C D Mitchell; M Blackstad; S W Sorensen
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

7.  Application of the polymerase chain reaction to the diagnosis of human toxoplasmosis.

Authors:  J D Johnson; P D Butcher; D Savva; R E Holliman
Journal:  J Infect       Date:  1993-03       Impact factor: 6.072

8.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

9.  Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients.

Authors:  A Roth; B Roth; G Höffken; S Steuber; K I Khalifa; K Janitschke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

10.  Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E. acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I. (T.) gondii.

Authors:  A W Cornelissen; J P Overdulve; M van der Ploeg
Journal:  Parasitology       Date:  1984-06       Impact factor: 3.234

View more
  22 in total

1.  Fatal disseminated toxoplasmosis in a toxoplasma seropositive liver transplant recipient.

Authors:  D Wendum; N Carbonell; M Svrcek; O Chazouilléres; J-F Fléjou
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

2.  Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients.

Authors:  C Franzen; M Altfeld; P Hegener; P Hartmann; G Arendt; H Jablonowski; J Rockstroh; V Diehl; B Salzberger; G Fätkenheuer
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Screening for active toxoplasmosis in patients by DNA hybridization with the ABGTg7 probe in blood samples.

Authors:  S O Angel; M Matrajt; J Margarit; M Nigro; E Illescas; V Pszenny; M R Amendoeira; E Guarnera; J C Garberi
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples.

Authors:  Fabio A Colombo; José E Vidal; Augusto C Penalva de Oliveira; Adrián V Hernandez; Francisco Bonasser-Filho; Roberta S Nogueira; Roberto Focaccia; Vera Lucia Pereira-Chioccola
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Urine sample used for congenital toxoplasmosis diagnosis by PCR.

Authors:  I Fuentes; M Rodriguez; C J Domingo; F del Castillo; T Juncosa; J Alvar
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes.

Authors:  J M Costa; C Pautas; P Ernault; F Foulet; C Cordonnier; S Bretagne
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Optimization and evaluation of a PCR assay for detecting toxoplasmic encephalitis in patients with AIDS.

Authors:  Priya Joseph; Maritza M Calderón; Robert H Gilman; Monica L Quispe; Jaime Cok; Eduardo Ticona; Victor Chavez; Juan A Jimenez; Maria C Chang; Martín J Lopez; Carlton A Evans
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS.

Authors:  J Lamoril; J M Molina; A de Gouvello; Y J Garin; J C Deybach; J Modaï; F Derouin
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

9.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients.

Authors:  M Dupon; J Cazenave; J L Pellegrin; J M Ragnaud; A Cheyrou; I Fischer; B Leng; J Y Lacut
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Utility of molecular and serodiagnostic tools in cerebral toxoplasmosis with and without tuberculous meningitis in AIDS patients: A study from South India.

Authors:  Sreenivas Adurthi; Anita Mahadevan; Radhika Bantwal; Parthasarthy Satishchandra; Sujay Ramprasad; Hema Sridhar; S K Shankar; Avindra Nath; R S Jayshree
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.